Amylyx Pharmaceuticals, Inc. Employment Agreements
13 Contracts & Agreements
- Form of Employment Agreement, between the Registrant and Camille Bedrosian (Filed With SEC on February 22, 2024)
- Amendment to Employment Agreement, effective as of November 27, 2023, by and between the Company and Patrick Yeramian (Filed With SEC on February 22, 2024)
- Amendment to Employment Agreement, effective as of December 1, 2022, by and between the Company and Patrick Yeramian (Filed With SEC on December 6, 2022)
- Form of Employment Agreement, between the Registrant and Patrick D. Yeramian, M.D. (to be entered into in connection with this offering) (Filed With SEC on January 3, 2022)
- Form of Employment Agreement, between the Registrant and Margaret Olinger (to be entered into in connection with this offering) (Filed With SEC on January 3, 2022)
- Form of Employment Agreement, between the Registrant and James Frates (to be entered into in connection with this offering) (Filed With SEC on January 3, 2022)
- Form of Employment Agreement, between the Registrant and Justin Klee (to be entered into in connection with this offering) (Filed With SEC on January 3, 2022)
- Form of Employment Agreement, between the Registrant and Josh Cohen (to be entered into in connection with this offering) (Filed With SEC on January 3, 2022)
- Employment Agreement, dated as of March 18, 2019, between the Registrant and Patrick D. Yeramian, M.D., as amended (as currently in effect) (Filed With SEC on January 3, 2022)
- Employment Agreement, dated as of May 13, 2019, between the Registrant and Margaret Olinger, as amended (as currently in effect) (Filed With SEC on January 3, 2022)
- Employment Agreement, dated as of January 25, 2021, between the Registrant and James Frates (as currently in effect) (Filed With SEC on January 3, 2022)
- Employment Agreement, dated as of August 1, 2015, between the Registrant and Justin Klee (as currently in effect) (Filed With SEC on January 3, 2022)
- Employment Agreement, dated as of July 1, 2015, between the Registrant and Josh Cohen (as currently in effect) (Filed With SEC on January 3, 2022)
